National Framework Agreement for Adalimumab Injection 1 April 2023
This is a contract result notice, not an open opportunity. Details from the official award data.
Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection commencing 1 April 2023<br/> <br/>Offer reference number: CM/PHR/22/5660<br/> <br/>CM/PHR/22/5660/01 - NHS Framework Agreement for the supply of Adalimumab Injection to South of England.
Period of framework: 1 April 2023 to 31 August 2024 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/02 - NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East.
Period of framework: 1 April 2023 to 28 February 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/03 - NHS Framework Agreement for the supply of Adalimumab Injection to London.
Period of framework: 1 April 2023 to 31 August 2025 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months<br/>CM/PHR/22/5660/04 - NHS Framework Agreement for the supply of Adalimumab Injection to North of England.
Period of framework: 1 April 2023 to 28 February 2026 with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months
What the notice asks for
Project Title: NHS National Framework Agreement
Project Title: NHS National Framework Agreement for the supply of Adalimumab Injection commencing 1 April 2023 Offer reference number: CM/PHR/22/5660 CM/PHR/22/5660/01.
NHS Framework Agreement for the supply
NHS Framework Agreement for the supply of Adalimumab Injection to South of England.
NHS Framework Agreement for the supply
NHS Framework Agreement for the supply of Adalimumab Injection to the Midlands and East.
NHS Framework Agreement for the supply
NHS Framework Agreement for the supply of Adalimumab Injection to London.
NHS Framework Agreement for the supply
NHS Framework Agreement for the supply of Adalimumab Injection to North of England.
Sentences from the notice that state an obligation, surfaced automatically and shown in the order they appear. Not an exhaustive list — always confirm against the tender documents.
What this notice demands of you
1 named, none in explicit obligation language. Each one is quoted from the notice.
National Framework Agreement for Adalimumab Injection 1 April 2023
Matched against the notice text, so this is a floor — the tender pack will demand things the notice never mentions. “Says must” means the quoted sentence itself used obligation language; anything ambiguous is left as a mention.
Make the case to bid
Reveal who to approach at NHS England, and generate a go-to-market strategy from their news, accounts and people.
Free to start. Named contacts come from published notices; the strategy is generated from the buyer’s news, accounts and people.
- OCID
- ocds-h6vhtk-037c6c
- Stage
- award · Awarded
- Source
- Find a Tender
- Buyer ref
- 008624-2023
Contains public sector information licensed under the Open Government Licence v3.0. Source data © Crown copyright.
Who wins this kind of work
The suppliers and buyers around this opportunity — drawn from official award data. Drag to orbit; click a node to explore.
Top suppliers & buyers in Medical Equipment & Pharmaceuticals
NHS England’s tender network